In this podcast, expert clinicians review strategies to engage patients with hemophilia A in their own care to improve overall patient satisfaction.

MedEdTalks - Hematology

Harnessing Shared Decision-making in Patients With Hemophilia A With Regina Butler, RN-BC and Courtney Thornburg, MD

In this podcast, a clinician and patient discuss his experience with hemophilia A, addressing patient concerns regarding this condition, its management, and preferred communication methods. 

Communicating With Patients for Optimized Hemophilia A Care With Regina Butler, RN-BC and Patient Advocate, Charles Felthaus

In this podcast, expert clinicians discuss recent and emerging treatment options with the potential to benefit patients with and without inhibitors.

New Treatment Options to Overcome Challenges in Hemophilia A Management With Regina Butler, RN-BC and Michael Callaghan, MD

In this podcast, expert clinicians discuss historical challenges in hemophilia A care and how recent therapeutic advancements help to overcome these limitations. 

V:ActivityHematology_Oncology20202020 Genentech Hemophilia A Podcast Series_K2552020 Genentech Hemophilia A Podcast Series Web-K255DeliverablesFinal Audio FilesK255 WITHOUT INTROS

Hemophilia A is an X-linked recessive disease primarily affecting males. An estimated 20,000 individuals in the United States have the disease. Conventional standard of care for patients with severe disease is factor VIII administration given prophylactically or to treat bleeding episodes. Almost 30% of patients treated with factor VIII develop neutralizing antibodies known as inhibitors, which require treatment with expensive bypassing agents. Newer approaches to treating hemophilia A include pegylated recombinant factor VIII agents with a longer half-life that allow for reduced dosing, as well as emicizumab, a bispecific antibody therapy that mimics the cofactor activity of factor VIII by binding to and bridging activated factor IX and factor X. In this 4-part CME podcast series, experts will summarize historical challenges in hemophilia A care; discuss how newer treatment options may benefit patients with and without inhibitors; and present strategies to promote shared decision-making and improve patient satisfaction. Additionally, faculty will speak with a patient advocate regarding treatment concerns and communication preferences. 

Hemophilia A: Incorporating New Therapeutic Strategies to Address Historical Treatment Challenges

MedEdTalks Hematology is a continuing medical education podcast for physicians to allow them to learn while on the go and obtain CME credits. The intended audience for this series is hematologists, hematology nurses (RNs) and nurse practitioners (NPs), oncology RNs, oncology NPs, hemophilia treatment center RNs, hemophilia treatment center NPs, and other health care professionals.

hubhopper

MedEdTalks - Hematology

hubhopper